[Pharmacotherapy in chronic kidney failure].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D010672:Phenytoin / Q000627:therapeutic use; D011485:Protein Binding; D013449:Sulfonamides / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D013449:Sulfonamides; D010672:Phenytoin; D004077:Digoxin; D004074:Digitoxin; D002994:Clofibrate; D014223:Triamterene
Pharmakotherapie bei chronischer Niereninsuffizienz